A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

NCT03982186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

471

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: JNJ-73763989
DRUG: Placebo for JNJ-73763989
DRUG: JNJ-56136379
DRUG: Placebo for JNJ-56136379
DRUG: Nucleos(t)ide Analog (NA)

Sponsor

Janssen Sciences Ireland UC